Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.035
Bid: 2.00
Ask: 2.07
Change: 0.00 (0.00%)
Spread: 0.07 (3.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.035
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Byotrol Sees Continuation Of Strong Demand

Thu, 14th May 2020 17:13

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Thursday and not separately reported by Alliance News:

----------

Byotrol PLC - infection prevention - Expects to generate record sales in the first quarter of 2020 and remains optimistic over continuation of high levels of demand for the first half. Sales in March and April each exceeded GBP1 million. Expects similar strong performance in May. Order book at the end of April stood at over GBP2 million. Agrees a technology license over Byotrol24 sanitiser spray with a consortium of investors and experienced market professionals under the umbrella of Integrated Resources International LLC, based in the US state of Tennessee. Inks multi-year license agreement with SC Johnson Professional Ltd for alcohol-free hand sanitisers.

----------

Sensyne Health PLC - clinical artificial intelligence technology - Sees rapid acceleration in the adoption of digital technologies in healthcare systems around the world due to virus outbreak. Expects revenue of GBP2.1 million for year to April-end, many times higher than GBP136,000 a year ago, slightly ahead of guidance provided in January 2020 and largely driven by momentum in the second half. Cash and cash equivalents of GBP31.6 million. Anticipates performing in line with the board's expectations for financial 2021.

----------

Coral Products PLC - plastic products - Predicts sales of GBP22.3 million for year to April 30, down 10% from GBP24.7 million a year ago and a small loss before taxation and intangibles. Annual earnings before interest, tax, depreciation and amortisation to also see a small year-on-year drop. Planning for a medium-term level return of demand. All staff members and directors take 20% pay cut for April and May. Negotiated payment holidays ranging from three to six months with lenders. Secures GBP1 million Coronavirus Business Interruption Loan.

----------

Global Invacom Group Ltd - satellite communications equipment - Pandemic had a negative impact for quarter to March 31, with revenue 31% lower year-on-year at USD26.4 million. To post quarterly loss of USD1.1 million mainly due to a reduction in revenue, which is the company's second-lowest since 2013. Continues to see demand from customers during the virus pandemic period.

----------

PipeHawk PLC - industrial technology - Core trading activity QM Systems experienced a reduction in order intake over the past two months. Taking steps to protect the business against a deeper than expected recession through the use of UK government's tax deferral schemes and the successful application for a GBP400,000 coronavirus loan. Furloughs several staff members to protect cash position. Confident in its ability to withstand the current situation.

----------

Gresham Technologies PLC - financial control and risk management software - Continues to operate at full capacity and remains confident in achieving 2020 guidance for adjusted earnings before interest, tax, depreciation and amortisation and cash Ebitda. Makes adjustments to operating plan to protect full-year earnings and ensure adequate liquidity. Expects to maintain current levels of investment in innovation and distribution for the foreseeable future.

----------

Iofina PLC - iodine - Gets loans totalling USD1.1 million under the US Small Business Administration's Paycheck Protection Program. Loans, or a portion of the loan, may be forgivable if loan proceeds are used for eligible purposes, including employee retention and payroll. Expects a significant majority of funds received to be eligible for forgiveness under the program. Iodine plant No 8 not operating currently due to brine supply issues. Expects viable brine volumes to return to IO No 8 plan in third-quarter of 2020 as the US economy recovers and oil prices stabilise. Four other IOsorb iodine plants are unaffected and continue to operate as expected.

----------

Safestyle UK PLC - windows and doors - Furloughs majority of its workforce as operations remain temporarily closed. Available liquidity in excess of GBP12 million. Planning to restart commercial operations in a phased manner in line with Covid-19 Secure government guidelines. Expecting to restart operations, including manufacturing, installations, surveying and selling activities by the end of May. Impossible to provide financial guidance 2020 without further clarity on virus impact.

----------

ImmuPharma PLC - drug discovery - Lupuzor may help to reduce or perhaps prevent the occurrence of the cytokine storm seen in Covid-19 patients. Further exploratory work is ongoing to assess Lupuzor's possible potential and clinical program in Covid-19 patients.

----------

Duke Royalty Ltd- capital provider - Elected to either accrue, capitalise or equitise its monthly cash payments in the short term with the intention of alleviating the negative cashflow impacts for its royalty partners during this time of unprecedented financial stress. Cash revenue received in April totalled over GBP600,000, down from GBP1 million received in March. Liquidity position strong, with cash on hand of over GBP3 million and additional liquidity of GBP18 million via a revolving line of credit with Honeycomb Investment Trust. To pay shareholders a scrip dividend instead of its normal cash dividend.

----------

Eurocell PLC - window, door and roofline PVC products - Implementing final steps towards re-opening of the business. Encouraged with robust trading over the first three days of re-opening, although it is not yet clear whether this is a result of pent up or underlying demand. Fit-out of the new warehouse remains on track and is expected to be operational early in 2021.

----------

Wincanton PLC - logistics - April revenue down 15% year-on-year. Furloughs 15% of workforce; board and executive management take temporary 20% pay cut; deferral of pension recovery payments; tax payments deferred until fourth-quarter; non-business capital expenditure delayed and final dividend suspended. Additional liquidity secured through a GBP40 million revolving credit facility extension, bringing the total available facility to GBP181 million. Performance for the year to March-end to be in line with market expectations with revenue growth of over 5%.

----------

Cairn Homes PLC - homebuilding - Implements phased reopening of residential construction sites from May 18. Given the productivity challenges and the cost implications for the broader industry in Ireland, there may be a significantly lower number of new homes completed in 2020. Closed and current forward sales pipeline of 863 units as of Wednesday. Strong gross cash position of EUR156 million.

----------

CEPS PLC - industrial trading group - Director David Horner loans GBP125,000 to provide additional working capital during the current virus situation. Loan, which is unsecured, carries zero interest and has no fixed repayment date.

----------

Dart Group PLC - leisure travel & logistics - Confirmed as an eligible issuer for the Bank of England Covid Corporate Financing Facility and has put in place a GBP300 million commercial paper programme to facilitate issuance under it. The loan will be used to provide standby liquidity, should that be required, and is currently unutilised.

----------

Totally PLC - healthcare services - Unit Vocare Ltd secures number of extensions to existing contracts across England worth a total of GBP19.6 million. Under the terms of the extensions, Vocare will continue to provide vital GP Out of Hours, NHS 111 and Integrated Urgent Care Services to several NHS Commissioners across the breadth of England, including southwest London, Staffordshire and Vale of York. Mobilised Planned Care and Insourcing divisions to ensure they are ready to recommence operations and support the National Healthcare Service as soon as these services restart across the UK.

----------

Arbuthnot Banking Group PLC - private banking - Traded well up to the introduction of the coronavirus lockdown. At the end of March, customer loan balances were 35% higher than the prior year and had increased by 4% from the level reported at December 31 2019. New loan origination volumes were 38% greater year-on-year for the quarter to March-end. Customer deposit balances increased by 2% from the level at the 2019-end. No staff have been placed on furlough or made redundant. Continued to pay all tax liabilities by their original due dates. Remained open to new introductions and lending opportunities and has funded GBP26 million of new loans during the lockdown. To date the core lending portfolios have seen modest take up of payment holiday requests.

----------

Mercia Asset Management PLC - capital provider - Investee Medherant Ltd, a transdermal drug delivery company, enters into a partnership with Cycle Pharmaceuticals to develop new products using Medherant's proprietary TEPI Patch technology. Under the partnership, Medherant will receive an initial upfront licence payment with an additional upfront payment for each candidate drug targeted. Medherant will also receive royalty payments on future sales of the products developed under the partnership, using the TEPI Patch platform.

----------

Symphony International Holdings Ltd - consumer businesses investment - Net Asset Value at March 31 USD0.6043, down from USD0.9805 at December-end. Change in NAV was predominantly due to a 53% decline in the share price of Minor International Pcl, a depreciation in Thai baht and other negative movements in the parameters used to value unlisted investments.

----------

Mountfield Group PLC - construction support services - Unit Connaught Access Flooring Ltd secures GBP1.2 million contract to install raised access flooring for a commercial office refurbishment project at Canary Wharf, London.

----------

React Group PLC - cleaning, hygiene and decontamination - Awarded a contract to provide specialist deep cleaning services on a regular basis to one of its customers operating in the rail sector. This is part of essential services and not Covid-19 related. The initial contract, worth approximately GBP400,000, will run for a period of 35-weeks through to the end of 2020 and is incremental to the work REACT carries out for this customer on a regular basis.

----------

Bango PLC - mobile commerce company - Signs a significant multi-year platform agreement with a major global telecoms provider. Deal is for an initial period of three-years and is worth, in aggregate, at least GBP1.5 million, with opportunity for Bango to earn additional revenue over this three-year period. Under the agreement, the telecoms provider will deliver a range of third-party products and services to its customers through the Bango platform and will benefit from Bango data insights to optimise the targeting of product offers.

----------

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 12:52

Immupharma jumps amid new IP strategy for P140 technology platform

(Alliance News) - Immupharma PLC on Tuesday announced a new intellectual property strategy to significantly enhance the patent life and commercial value for its P140 technology platform.

Read more
25 Mar 2024 12:20

Incanthera says first order from skincare deal doubles

(Alliance News) - ImmuPharma PLC on Monday noted updates on Incanthera PLC's commercial skincare deal with Marionnaud, which was first announced in December 2023.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 10:55

AIM WINNERS & LOSERS: ImmuPharma order doubles; Aeorema swings to loss

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
6 Mar 2024 13:05

EARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue up

(Alliance News) - The following is a round-up of earnings and trading updates of London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
19 Dec 2023 17:52

EARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrows

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
18 Dec 2023 12:18

IN BRIEF: Incanthera signs skincare stocking deal, raises GBP1 million

Incanthera PLC - develops technologies in dermatology and oncology - Raises GBP1.0 million in equity to support a deal that will see a major retailer stock Incanthera's 'Skin + Cell' range of skincare products. Raises GBP800,000 from the subscription to 11.4 million new shares at 7 pence each by new and existing institutional investors. At the same price, the University of Bradford converts GBP200,000 that is owed to it by Incanthera into 2.9 million new shares. The university, a founding shareholder in Incanthera, will own 11.2% of the enlarged share capital, with all the newly issued shares representing 15.5% of this. Incanthera also grants warrants to advisers to subscribe for another 800,000 new shares at the same price of 7p over the next 10 years. ImmuPharma PLC, which currently has a 12.7% stake in Incanthera, says it is "delighted" with the announcement of the skincare deal and successful fundraise.

Read more
7 Sep 2023 17:07

TRADING UPDATES: RA International loss narrows as revenue grows

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
31 Aug 2023 13:05

ImmuPharma launches GBP2 million fund raise as interim loss narrows

(Alliance News) - ImmuPharma PLC on Thursday announced a share placing and a retail share offer to raise just under GBP2 million, while it also reported a narrowed loss in the first half of the year on reduced expenses.

Read more
21 Aug 2023 12:33

ImmuPharma agrees 12 month extension to Incanthera warrant instrument

(Alliance News) - Incanthera PLC and ImmuPharma PLC on Monday agreed a 12 month extension to their warrant instrument.

Read more
23 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
Friday 30 June 
Argo Blockchain PLCAGM
Ascent Resources PLCAGM
Bluejay Mining PLCAGM
Caspian Sunrise PLCAGM
Codex Acquisitions PLCAGM
Domino's Pizza Group PLCGM re directors' remuneration policy
Fenikso LtdAGM
Fiinu PLCAGM
FireAngel Safety Technology Group PLCAGM
GENinCode PLCAGM
Hemogenyx Pharmaceuticals PLCAGM
Hiro Metaverse Acquisitions I SAAGM
i3 Energy PLCGM re premium share cancellation
ImmuPharma PLCAGM
Inspired PLCAGM
Jadestone Energy PLCAGM
Kanabo Group PLCAGM
Kefi Gold & Copper PLCAGM
Kistos Holdings PLCAGM
KRM22 PLCAGM
Kropz PLCAGM
LoopUp Group PLCAGM
Medica Group PLCAGM
Mirriad Advertising PLCAGM
Rockfire Resources PLCAGM
Savannah Energy PLCAGM
Strip Tinning Holdings PLCAGM
ThomasLloyd Energy Impact Trust PLCAGM
URA Holdings PLCAGM
World Chess PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 Jun 2023 12:02

IN BRIEF: ImmuPharma to start next two phases of Lupuzor trial

ImmuPharma PLC - London-based drug discovery and development company - Will start phases two and three of the clinical trial for Lupuzor in the seocnd half of 2023, following talks with the US Food & Drug Administration. Says the clinical trial will be supported by Avion Pharmaceuticals. Adds further details of the trial will be shared at a later stage. Lupuzor, or P140, is a potential treatment for Lupus disease.

Read more
18 May 2023 12:12

IN BRIEF: ImmuPharma rises on FDA feedback for neurological disease

ImmuPharma PLC - London-based drug discovery and development company - Gets positive support and guidance from the US Food & Drug Administration after a pre-investigational new drug meeting, which confirms the route for a Phase 2/3 adaptive clinical study of P140 in chronic idiopathic demyelinating polyneuropathy. Says the feedback recognises that P140 is suitable to be studied in another disease indication, in addition to systemic lupus erythematosus.

Read more
11 May 2023 11:48

IN BRIEF: ImmuPharma annual loss narrows as R&D spending reduced

ImmuPharma PLC - London-based drug discovery and development company - Posts no revenue for 2022, compared to GBP118,350 for 2021. Pretax loss narrows to GBP4.5 million from GBP8.9 million a year earlier, as operating loss reduces to GBP3.0 million from GBP6.6 million. Research and development expenditure is GBP2.0 million, down from GBP3.7 million in 2021. Chief Executive Officer Tim McCarthy says: "As a board, we remain focused on bringing our two key late stage clinical assets, Lupuzor for lupus and CIDP closer to the market."

Read more
19 Apr 2023 15:40

IN BRIEF: ImmuPharma says US FDA confirms date for Lupuzor meeting

ImmuPharma PLC - London-based drug discovery and development company - Notes the US Food & Drug Administration has set a date of June 7 for a type-C meeting to provide guidance on the phase 2/3 adaptive study of Lupuzor, or P140, in patients with systemic lupus erythematosus, a common type of immune disease lupus. Says this follows the announcement in late March, when it submitted a phase 2/3 clinical trial protocol to the US FDA testing the Lupuzor treatment for lupus patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.